Incyte
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell Incyte and other ETFs, options, and stocks.About INCY
Incyte Corp. is a biopharmaceutical company, which engages in the discovery, development, and commercialization of proprietary therapeutics. It focuses on hematology and oncology, and inflammation and autoimmunity therapeutic areas.
INCY Key Statistics
Stock Snapshot
As of today, Incyte(INCY) shares are valued at $114.43. The company's market cap stands at 22.82B, with a P/E ratio of 16.50.
On 2026-07-14, Incyte(INCY) shares started trading at $115.97, with intraday highs of — and lows of —.
Trading activity shows a volume of 0, compared to an average daily volume of 1.7M.
The stock's 52-week range extends from a low of $67.17 to a high of $118.97.
The stock's 52-week range extends from a low of $67.17 to a high of $118.97.
INCY News
Analyst Judah Frommer from Morgan Stanley maintained a Hold rating on Incyte and keeping the price target at $103.00. TipRanks Welcomes a New ETF – NYSE:RANK Ti...
Barclays raised the firm’s price target on Incyte (INCY) to $134 from $117 and keeps an Overweight rating on the shares. The firm adjusted the price target as p...
...
Analyst ratings
55%
of 29 ratingsMore INCY News
VWD is the most common inherited bleeding disorder, affecting about 1% of the population. It is caused by a deficiency or malfunction of the von Willebrand fac...
Incyte (INCY) announced complete safety and efficacy data from all patients enrolled in the Phase 1/2 multidose study of VGA039, a Protein S-targeting, investig...
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.